article thumbnail

Zerion and Insud to develop Dispersome formulations of drugs

Pharmaceutical Technology

Zerion Pharma has entered a partnership with Insud Pharma for the development and marketing of drug products using Zerion Pharma's solubility-boosting Dispersome technology. . Under the deal, Zerion will handle the development of Dispersome formulations of marketed drugs.

article thumbnail

EdiGene Expands Management Team by Appointment of Head of US Subsidiary Dr. Bo Zhang and Head of Business Development Dr. Kehua Fan

The Pharma Data

.–( BUSINESS WIRE )– EdiGene, Inc. which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases, today announced the appointment of Bo Zhang, Ph.D., as Head of Business Development. Both will report to Dr. Dong Wei, CEO of EdiGene.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SCOPE - the go-to destination for sharing innovative approaches in clinical operation

Outsourcing Pharma

Dawn Kaminski is vice president, of business development (BD) operations at eClinical Solutions and is responsible for working with the BD team as a subject matter expert for services and technology, strategically positioning the organization to acquire new business and expand the business offerings within current customers.

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

How the NIHR’s Patient Engagement in Clinical Development service can help. Gareth Powell is a business development officer for the NIHR Clinical Research Network (CRN). Gareth has been with the Clinical Research Network since 2009. Gaining patient input on marketing and recruitment materials.

article thumbnail

Bispecific CD3 Molecules in Oncology Analytical Handbook 2020: 67 Companies Plus Partners who are Developing 148 Drugs Where 127 are in Active Development – ResearchAndMarkets.com

BioTech 365

DUBLIN–(BUSINESS WIRE)–The “Bispecific CD3 Molecules in Oncology: Analytical Tool” report has been added to ResearchAndMarkets.com’s offering.

article thumbnail

Global Protein Kinase Inhibitors in Oncology Analytical Handbook 2020 – ResearchAndMarkets.com

BioTech 365

DUBLIN–(BUSINESS WIRE)–The “Protein Kinase Inhibitors in Oncology: Analytical Tool” report has been added to ResearchAndMarkets.com’s offering.

Protein 40
article thumbnail

2020 RNA Therapies in Oncology Analytical Tool – ResearchAndMarkets.com

BioTech 365

DUBLIN–(BUSINESS WIRE)–The “RNA Therapies in Oncology: Analytical Tool” report has been added to ResearchAndMarkets.com’s offering.

RNA 40